Main > ONCOLOGY (**) > Lymphoma>NHL>B-Cell>FL R *** > Treatment > Co: USA. B. Lenalidomide+RituxiMAb>



Co: USA. B. Lenalidomide+RituxiMAb>'s subsections
(*) EU Approval Date: 2019. 12.20.
(*) USA Approval Date: 2019. 05.28.
>adult patients with previously tre
Chemotherapy-Free Combination
Company
Grade 1-3a
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 3
Patent>UpDate: 2019. 12.24.
TradeMark
TradeMark Web-Site

Co: USA. B. Lenalidomide+RituxiMAb>'s products
This section has no products